COMMUNIQUÉS West-GlobeNewswire

JellyFil Publishes Updated 2026 Product Information for Its Premium Gummy Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026
Florida-distributed gummy supplement brand details current ingredients, pricing, refund policy, and customer service processes for 2026 Largo, FL, June 20, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
BreathEaseX Publishes Updated 2026 Product Information for Its Oral Spray Dietary Supplement, Including Full Ingredient List, Pricing, Refund Policy, and Customer Service Details
20/06/2026
Aurora, Colorado-based dietary supplement company refreshes publicly available product disclosures, reaffirms its 60-day money-back guarantee, and details current ordering, shipping, and support processes for 2026 [...]
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
19/06/2026
VANCOUVER, British Columbia, June 19, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“ Eupraxia ” or the “ Company ”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
19/06/2026
SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
19/06/2026
REGULATED INFORMATION June 19, 2026, 10:30pm CET / 4:30pm ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium (hereinafter the “ Company ”) Invitation to attend the [...]
Invitation à assister à l'assemblée générale extraordinaire des actionnaires de la Société qui se tiendra le 9 juillet 2026
19/06/2026
INFORMATIONS RÉGLEMENTÉES Le 19 juin 2026, 22:30h CET / 16:30h ET NYXOAH SA (Euronext Brussels/Nasdaq: NYXH) Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgique (ci-après la « Société ») Invitation à assister à l' [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026
NOVATO, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/06/2026
CAMBRIDGE, Mass., June 19, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting [...]
Dr. Austin Harris, MD Announces NAD+ IV Infusion Therapy Availability at NeuroRelief for Cellular Health and Cognitive Wellness Support in 2026
19/06/2026
SHERMAN OAKS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Dr. Austin Harris, MD , founder of NeuroRelief Ketamine & Infusion Therapy , has announced the availability of NAD+ IV infusion therapy as part of the clinic’s [...]
Boston Dental Named The Best Dentist in Boston
19/06/2026
Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services Boston, MA, June 19, 2026 (GLOBE NEWSWIRE) -- Boston Dental, a leader in dental and aesthetic services, has [...]
Le professeur Mohamed Shamji prend la présidence de l’EAACI à l’issue du Congrès 2026 qui s’est tenu à Istanbul
19/06/2026
Une nouvelle direction prend ses fonctions alors que la communauté mondiale des spécialistes de l’allergie poursuit l’ambition Vision Zéro pour un avenir délivré du poids des allergies et de l’asthme ISTANBUL, 19 juin [...]
Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities' first inpatient behavioral health treatment and recovery facility
19/06/2026
YAKIMA, Wash., June 19, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that the Columbia Valley Center for Recovery (CVCR) in Kennewick will open on Saturday, June 20, marking an important expansion [...]
FDA Approves Labeled Strength Update of TWIRLA® (levonorgestrel/ethinyl estradiol) Birth Control Patch
19/06/2026
FLORHAM PARK, N.J., June 19, 2026 (GLOBE NEWSWIRE) -- Exeltis USA, Inc. (Exeltis), a global pharmaceutical company specializing in women’s health, announced that the U.S. Food and Drug Administration (FDA) has approved [...]
Glass House Brands Announces Voting Results Following Annual Meeting
19/06/2026
LONG BEACH, Calif. and TORONTO, June 19, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that, at the Company's annual meeting (the " [...]
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
19/06/2026
~ AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early biological signals of potential therapeutic activity ~ LEXINGTON, Mass. and AMSTERDAM, June 19, 2026 (GLOBE NEWSWIRE [...]
Lite Strategy to Attend Panel at Litecoin Foundation Summit in Amsterdam
19/06/2026
Panel to Address Litecoin's Institutional Evolution, Marking the First Time a Digital Asset Treasury Company Has Taken the Stage at the Litecoin Foundation's Annual Summit SAN DIEGO, June 19, 2026 (GLOBE NEWSWIRE) -- [...]
Communiqué de presse : Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple
19/06/2026
Sarclisa de Sanofi en formulation sous-cutanée approuvé au Japon pour les patients atteints de myélome multiple Approbation basée sur plusieurs études, y compris l’étude pivot de phase 3 IRAKLIA qui a démontré une [...]
Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma
19/06/2026
Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on multiple studies, including the pivotal IRAKLIA phase 3 study which demonstrated non-inferior efficacy [...]
Communiqué de presse : Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé
19/06/2026
Sanofi et HEC Paris lancent la « Sanofi MBA Life Sciences Scholarship » pour accompagner les futurs leaders de la santé Paris, le 19 juin 2026 — Sanofi et HEC Paris annoncent le lancement de la “ Sanofi MBA Life [...]

Pages